|
|
Article: Ariad's Stem Cell Technology Shows Promise In Animals.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Senior Staff Writer
The problem with gene therapy isn't inserting a gene into a cell - that biotechnology can do - it's getting the gene inserted into enough cells to provide a therapeutic benefit.
Ariad Pharmaceuticals Inc.'s ARGENT (Ariad Regulated Gene Therapy) stem cell therapy technology might help science clear this hurdle. Researchers from Cambridge, Mass.-based Ariad and the University of Washington demonstrated that a small number of genetically modified bone marrow cells could be activated to grow in vivo into a large population. The study was published in the Sept. 15, 2002, issue of Blood. Although the research is in its early stages, Ariad ...